Novel characteristics of soluble fibrin: hypercoagulability and acceleration of blood sedimentation rate mediated by its generation of erythrocyte-linked fibers.

Atomic force microscopy Clot lysis Erythrocyte sedimentation Molecular imprints Soluble fibrin Thromboelastography

Journal

Cell and tissue research
ISSN: 1432-0878
Titre abrégé: Cell Tissue Res
Pays: Germany
ID NLM: 0417625

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 11 08 2021
accepted: 09 02 2022
pubmed: 12 3 2022
medline: 6 4 2022
entrez: 11 3 2022
Statut: ppublish

Résumé

Soluble fibrin (SF) in blood consists of monomers lacking both fibrinopeptides A with a minor population in multimeric clusters. It is a substantial component of isolated fibrinogen (fg), which spontaneously self-assembles into protofibrils progressing to fibers at sub-physiologic temperatures, a process enhanced by adsorption to hydrophobic and some metal surfaces. Comparisons of SF-rich (FR) and SF-depleted (FD) fg isolates disclosed distinct molecular imprints of each via an adsorption/desorption procedure using gold surfaced silica microplates. Accelerated plasminogen activator-induced lysis and decreased stiffness (G') of thrombin-induced FR fg clots were revealed by thomboelastography. Erythrocyte sedimentation (ESR) in afibrinogenemic plasma (Hematocrit 25-33%) was accelerated by FR fg nearly threefold that of FD fg. Stained smears disclosed frequent rouleaux formations and fibers linking stacked erythrocytes in contrast to no rouleaux by FD fg. Rouleaux formations were more pronounced at 4 °C than at ambient temperatures and at fiber-membrane contacts displayed irregular, knobby membrane contours. One of several FR fg isolates also displayed incomplete fiber networks in cell-free areas. What is more, pre-mixing FR fg with each of three monoclonal IgG anti-fg antibodies at 1.5 mol/mol fg, that inhibited fibrin polymerization, prevented rouleaux formation save occasional 2-4 erythrocyte aggregates. We conclude that spontaneously generated SF fibers bound to erythrocytes forming intercellular links culminating in rouleaux formation and ensuing ESR acceleration which in clinical settings reflects hypercoagulability. Also, the results can explain the reported fg binding to erythrocytes via ligands such as CD47, stable in vivo RBC aggregates in capillaries, and red areas of pathologic thrombi.

Identifiants

pubmed: 35275281
doi: 10.1007/s00441-022-03599-9
pii: 10.1007/s00441-022-03599-9
pmc: PMC8913327
doi:

Substances chimiques

Fibrin 9001-31-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

479-491

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL135254
Pays : United States
Organisme : national science foundation
ID : NSF DMR 0606387
Organisme : NHLBI NIH HHS
ID : NIH RO1-HL135254.
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022. The Author(s).

Références

Eur J Clin Invest. 1995 Jul;25(7):523-8
pubmed: 7556371
Thromb Haemost. 2003 Mar;89(3):409-19
pubmed: 12624622
J Fr Ophtalmol. 1990;13(10):500-5
pubmed: 2081840
Biophys J. 2020 Jan 7;118(1):172-181
pubmed: 31735326
J Thromb Haemost. 2013 May;11(5):993-5
pubmed: 23413924
Blood. 2019 Feb 7;133(6):511-520
pubmed: 30523120
JAMA Surg. 2018 Sep 1;153(9):826-833
pubmed: 29898202
Exp Ther Med. 2017 Sep;14(3):1909-1918
pubmed: 28962103
Blood Coagul Fibrinolysis. 1992 Aug;3(4):361-70
pubmed: 1420813
J Thromb Haemost. 2009 Feb;7(2):355-9
pubmed: 19036059
Biochim Biophys Acta. 1987 Nov 2;904(1):81-91
pubmed: 2959322
Thromb Res. 1979;15(1-2):287-9
pubmed: 483280
Semin Immunopathol. 2012 Jan;34(1):43-62
pubmed: 22037947
Blood. 1987 Mar;69(3):950-2
pubmed: 3814824
Acta Haematol. 1957 Apr;17(4):237-46
pubmed: 13434757
Aust Prescr. 2015 Jun;38(3):93-4
pubmed: 26648629
Analyst. 2016 Oct 07;141(19):5607-17
pubmed: 27441317
Biochim Biophys Acta. 2012 Mar;1818(3):481-90
pubmed: 22079249
Thromb Res. 1996 Jan 15;81(2):263-9
pubmed: 8822141
Proc Natl Acad Sci U S A. 1980 Sep;77(9):5069-73
pubmed: 6933547
FEBS Lett. 2002 Apr 24;517(1-3):41-4
pubmed: 12062406
Blood. 2013 Mar 7;121(10):1712-9
pubmed: 23305734
Biomacromolecules. 2012 May 14;13(5):1259-68
pubmed: 22423652
Biochemistry. 2000 Dec 26;39(51):15730-41
pubmed: 11123898
Nature. 1964 Jul 18;203:312
pubmed: 14201780
J Obstet Gynaecol Br Emp. 1953 Jun;60(3):409-15
pubmed: 13062007
Adv Protein Chem. 2005;70:247-99
pubmed: 15837518
J Exp Med. 1962 Nov 1;116:687-707
pubmed: 13988371
Biochemistry. 1998 Jun 16;37(24):8637-42
pubmed: 9628725
Am J Med. 2015 Aug;128(8):916-21
pubmed: 25827358
J Thromb Haemost. 2010 Dec;8(12):2727-35
pubmed: 20880206
Sci Rep. 2014 Mar 11;4:4348
pubmed: 24614613
Nanomedicine (Lond). 2018 Oct;13(19):2491-2505
pubmed: 30311540
Biochim Biophys Acta. 1969 Dec 23;194(2):462-9
pubmed: 4189426
Thromb Res. 2002 Jan 1;105(1):3-13
pubmed: 11864700
J Am Chem Soc. 1948 Sep;70(9):3103-8
pubmed: 18882550
Ann Clin Biochem. 2007 Sep;44(Pt 5):449-54
pubmed: 17761030
Thromb Res. 1995 May 15;78(4):303-13
pubmed: 7631311
Geburtshilfe Frauenheilkd. 1975 Jul;35(7):518-25
pubmed: 1213264
TH Open. 2021 Jul 06;5(3):e273-e285
pubmed: 34240000
Haemophilia. 2011 Nov;17(6):890-4
pubmed: 21435117
Clin Dermatol. 2011 Nov-Dec;29(6):697-703
pubmed: 23293796
Subcell Biochem. 2017;82:405-456
pubmed: 28101869
Blood. 2011 Apr 28;117(17):4609-14
pubmed: 21248064
Biochemistry. 1987 Apr 21;26(8):2389-400
pubmed: 3620452
J Biol Chem. 1974 Jul 25;249(14):4656-64
pubmed: 4276463
Biochemistry. 1966 Sep;5(9):2829-35
pubmed: 5961868
Am J Med. 2009 Dec;122(12):1128-35
pubmed: 19958891
J Thromb Haemost. 2015 Apr;13(4):570-9
pubmed: 25393591
BJOG. 2001 Nov;108(11):1164-7
pubmed: 11762656
Thromb Res. 2014 Jun;133(6):1115-23
pubmed: 24679643
Circulation. 2013 Sep 17;128(12):1276-80
pubmed: 23969697
Biochemistry. 2007 Aug 7;46(31):9133-42
pubmed: 17630702
Arch Biochem. 1947 May;13(2):231-6
pubmed: 20240449
J Neurosci Rural Pract. 2014 Jan;5(1):40-5
pubmed: 24741248
Semin Thromb Hemost. 2018 Apr;44(3):239-248
pubmed: 28946150
Biochim Biophys Acta. 1984 Sep 19;776(1):151-8
pubmed: 6477901
Blood. 2020 Jul 23;136(4):489-500
pubmed: 32492712

Auteurs

Dennis K Galanakis (DK)

Dept. of Pathology, Stony Brook University School of Medicine, Stony Brook, NY, USA. dennis.galanakis@stonybrookmedicine.edu.

Anna Protopopova (A)

Dept. of Cell and Developmental Biology, Univ. of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Kao Li (K)

Dept. of Materials Science and Engineering, Stony Brook University, Stony Brook, NY, USA.

Yingjie Yu (Y)

Dept. of Materials Science and Engineering, Stony Brook University, Stony Brook, NY, USA.

Tahmeena Ahmed (T)

Dept. of Pathology, Stony Brook University School of Medicine, Stony Brook, NY, USA.

Lisa Senzel (L)

Dept. of Pathology, Stony Brook University School of Medicine, Stony Brook, NY, USA.

Ryan Heslin (R)

Dept. of Medicine, Stony Brook University School of Medicine, Stony Brook, NY, USA.

Mohamed Gouda (M)

Dept. of Physiology and Biophysics, Stony Brook University, Stony Brook, NY, USA.

Jaseung Koo (J)

Dept. of Materials Science and Engineering, Stony Brook University, Stony Brook, NY, USA.

John Weisel (J)

Dept. of Cell and Developmental Biology, Univ. of Pennsylvania School of Medicine, Philadelphia, PA, USA.

Marilyn Manco-Johnson (M)

Heme/Onc and Bone Marrow Transplantation, Children's Hospital, Univ. of Colorado, Aurora, CO, USA.

Miriam Rafailovich (M)

Dept. of Materials Science and Engineering, Stony Brook University, Stony Brook, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH